Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Rehmannia glutinosa var. purpurea
The wine-prepared and steam-cooked form of Rehmannia root; black sticky appearance; strongest kidney yin and essence tonic in TCM.
Shu Di Huang (Rehmannia glutinosa var. purpurea) is a wine-processed root used in Traditional Chinese Medicine as a premier tonic for kidney yin and blood deficiency. Modern research indicates hematopoietic, anti-aging, immunomodulatory, and antidiabetic activities, attributed to compounds such as catalpol, rehmanniosides, and polysaccharides. Its clinical evidence is limited to pilot and preclinical studies, supporting traditional applications for conditions like anemia, premature aging, and metabolic disorders.
Catalpol and rehmanniosides exhibit antioxidant and anti-inflammatory effects by modulating Nrf2/ARE and NF-κB pathways, reducing oxidative stress and apoptosis. Polysaccharides stimulate hematopoiesis via upregulation of erythropoietin and colony-stimulating factors, while iridoid glycosides improve insulin sensitivity through PPARγ activation and GLUT4 translocation. Additionally, these compounds enhance immune function by promoting T-cell proliferation and cytokine secretion, and may protect against neurodegeneration via BDNF signaling.
The wine-prepared and steam-cooked form of Rehmannia root; black sticky appearance; strongest kidney yin and essence tonic in TCM.
Shu Di Huang (Rehmannia glutinosa var. purpurea) is a wine-processed root used in Traditional Chinese Medicine as a premier tonic for kidney yin and blood deficiency. Modern research indicates hematopoietic, anti-aging, immunomodulatory, and antidiabetic activities, attributed to compounds such as catalpol, rehmanniosides, and polysaccharides. Its clinical evidence is limited to pilot and preclinical studies, supporting traditional applications for conditions like anemia, premature aging, and metabolic disorders.
Catalpol and rehmanniosides exhibit antioxidant and anti-inflammatory effects by modulating Nrf2/ARE and NF-κB pathways, reducing oxidative stress and apoptosis. Polysaccharides stimulate hematopoiesis via upregulation of erythropoietin and colony-stimulating factors, while iridoid glycosides improve insulin sensitivity through PPARγ activation and GLUT4 translocation. Additionally, these compounds enhance immune function by promoting T-cell proliferation and cytokine secretion, and may protect against neurodegeneration via BDNF signaling.